Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
K. S. Salmela, R. P. Roine, J. Höök-Nikanne, T. U. Kosunen & M. Salaspuro. (1994) Effect of Bismuth and Nitecapone on Acetaldehyde Production by Helicobacter pylori. Scandinavian Journal of Gastroenterology 29:6, pages 528-531.
Read now
Read now
T. Rokkas & G. E. Sladen. (1988) Bismuth: Effects on Gastritis and Peptic Ulcer. Scandinavian Journal of Gastroenterology 23:sup142, pages 82-86.
Read now
Read now
B. Hallerbäuck, J.-H. Solhaug, L. Carling, H. Glise, T. Hallgren, I. Kagevi, L.-E. Svedberg & L. Wäuhlby. (1987) Recurrent Ulcer after Treatment with Cimetidine or Sucralfate. Scandinavian Journal of Gastroenterology 22:7, pages 791-797.
Read now
Read now
J. B. Elder. (1986) Recent Experimental and Clinical Studies on the Pharmacology of Colloidal Bismuth Subcitrate. Scandinavian Journal of Gastroenterology 21:sup122, pages 14-16.
Read now
Read now
Articles from other publishers (22)
Muhammad Awais, Aqsa Aizaz, Arooba Nazneen, Qurat ul Ain Bhatti, Memoona Akhtar, Abdul Wadood & Muhammad Atiq Ur Rehman. (2022) A Review on the Recent Advancements on Therapeutic Effects of Ions in the Physiological Environments. Prosthesis 4:2, pages 263-316.
Crossref
Crossref
Reinaldo Barreto Oriá & Gerly Anne de Castro BritoFlávia Almeida Santos & Vietla Satyanarayana Rao. 2016. Sistema Digestório: Integração Básico-Clínica. Sistema Digestório: Integração Básico-Clínica
645
670
.
E. A. Marcus, G. Sachs & D. R. Scott. (2015)
Colloidal bismuth subcitrate impedes proton entry into
Helicobacter pylori
and increases the efficacy of growth-dependent antibiotics
. Alimentary Pharmacology & Therapeutics 42:7, pages 922-933.
Crossref
Crossref
Ruiguang Ge, Zhuo Chen & Qinglu Zhou. (2012) The actions of bismuth in the treatment of Helicobacter pylori infections: an update. Metallomics 4:3, pages 239.
Crossref
Crossref
C Ivanov, O Petkov, P Petrov, M Taskov, R Athanassova, E Tsvetkova, V Kotsev, G Lyutakov, G Nikolov & E Savov. (1996)
Synthesis, Gastroprotective, Antisecretory and Anti-helicobacter Effect of
N
-[3-(3-(1-Piperidinylmethyl) phenoxy)propyl]-hydroxyacetamide 2-Hydroxypropane-1,2,3-tricarboxylate Bismuth (3+) Complex (MX1)-MX1
. Journal of Pharmacy and Pharmacology 48:3, pages 297-301.
Crossref
Crossref
P E CoudronC W Stratton. (1995) Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases. Antimicrobial Agents and Chemotherapy 39:1, pages 66-69.
Crossref
Crossref
Tetsuo ARAKAWA, Shuji KIMURA, Toshiyuki UCHIDA, Kazuhide HIGUCHI, Takashi FUKUDA, Hajime NAKAMURA & Kenzo KOBAYASHI. (2007) Therapeutic Success with the Suppression of Helicobacter pylori of Intractable Gastric Ulcers. Digestive Endoscopy 6:3, pages 275-280.
Crossref
Crossref
Nicholas J. Talley. (1994) A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 106:5, pages 1174-1183.
Crossref
Crossref
P. Malfertheiner, M. Nilius & U. Kreusel. 1994. Basic and Clinical Aspects of Helicobacter pylori Infection. Basic and Clinical Aspects of Helicobacter pylori Infection
266
279
.
Stanislaw J. Konturek, Toman Brzozowski, Danuta Drozdowicz, J. Garlicki, J. Majka & J. Pytko-Polonczyk. (1991) Role of acid milieu in the gastroprotective and ulcer-healing activity of sucralfate. The American Journal of Medicine 91:2, pages S20-S29.
Crossref
Crossref
Efthimios Eleftheriadis, Katerina Kotzampassi, Emmanouel Tzartinoglou, Aziz Salem & Homeros Aletras. (1991) Colloidal bismuth subcitrate-induced changes on gastric mucosal hemodynamics in the rat: Gastric mucosal blood flow after CBS treatment. Gastroenterologia Japonica 26:3, pages 283-286.
Crossref
Crossref
J. W. Rademaker & R. H. Hunt. 1991. Pharmacology of Peptic Ulcer Disease. Pharmacology of Peptic Ulcer Disease
301
323
.
Sherwood L. Gorbach. (1990) Bismuth therapy in gastrointestinal diseases. Gastroenterology 99:3, pages 863-875.
Crossref
Crossref
Bronislaw L. Slomiany, Xiaoying Wang, Danuta Palecz, Kazuichi Okazaki & Amalia Slomiany. (1990) Participation of Phosphoinositides in Gastric Mucosal Protection by Colloidal Bismuth Subcitrate against Ethanol-Induced Injury. Alcoholism: Clinical and Experimental Research 14:4, pages 580-583.
Crossref
Crossref
S. PUGH & M. R. LEWIN. (2008) Mechanism of action of Roter (bismuth subnitrate) in patients with duodenal ulcer disease and healthy volunteers. Journal of Gastroenterology and Hepatology 5:4, pages 382-386.
Crossref
Crossref
S. D. RYDER, R. J. WALKER, H. JONES & J. M. RHODES. (2007) Rectal bismuth subsalicylate as therapy for ulcerative colitis. Alimentary Pharmacology & Therapeutics 4:4, pages 333-338.
Crossref
Crossref
B. Bradley, M. Singleton & A. Li Wan Po. (1989) BISMUTH TOXICITY—A REASSESSMENT. Journal of Clinical Pharmacy and Therapeutics 14:6, pages 423-441.
Crossref
Crossref
André Robert, Paul H. Guth, Karmen L. Schmidt & Thomas A. Miller. (1989) Response to an Editorial on Gastric Cytoprotection. Gastroenterology 96:2, pages 548-551.
Crossref
Crossref
Janneke De Wal. (1988) Mechanism of action of nonantisecretory agents. Digestive Diseases and Sciences 33:10, pages 1342-1342.
Crossref
Crossref
A. Garner. 1988. Advances in Peptic Ulcer Pathogenesis. Advances in Peptic Ulcer Pathogenesis
225
237
.
G. N. J. Tytgat, C. Y. Nio & B. T. J. van den Berg. 1988. Campylobacter pylori. Campylobacter pylori
195
203
.
G. Bertaccini & G. Coruzzi. 1988. Prostaglandins and Leukotrienes in Gastrointestinal Diseases. Prostaglandins and Leukotrienes in Gastrointestinal Diseases
75
80
.